Ignite Creation Date:
2024-05-06 @ 3:01 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04492488
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-05-06
First Post:
2020-07-23
Brief Title:
A Study of MRG002 in Patients with HER2-Positive Advanced Solid Tumors and Locally Advanced or Metastatic GastricGastroesophageal Junction GEJ Cancer
Sponsor:
Shanghai Miracogen Inc
Organization:
Shanghai Miracogen Inc
Organization Data
Organization:
Shanghai Miracogen Inc
Class:
INDUSTRY
Study ID:
MRG002-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai Miracogen Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None